373 related articles for article (PubMed ID: 19808515)
41. Molecular Imaging II. Preface.
Semmler W; Schwaiger M
Handb Exp Pharmacol; 2008; (185 Pt 2):vii-ix. PubMed ID: 18788125
[No Abstract] [Full Text] [Related]
42. The role of molecular imaging in drug discovery and development.
Hargreaves RJ
Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
[TBL] [Abstract][Full Text] [Related]
43. Analysis of ventricular function by MRI.
Zeitler E; Weikl A
Radiol Med; 1990 Jun; 79(6):696-700. PubMed ID: 2382039
[No Abstract] [Full Text] [Related]
44. Functional neuroimaging of Tourette syndrome: advances and future directions.
Butler T; Stern E; Silbersweig D
Adv Neurol; 2006; 99():115-29. PubMed ID: 16536357
[No Abstract] [Full Text] [Related]
45. Cardiac magnetic resonance predicts reversibility of cocaine-induced ventricular dysfunction.
Smedema JP
Cardiovasc J Afr; 2009; 20(3):198-9. PubMed ID: 19575088
[TBL] [Abstract][Full Text] [Related]
46. Should we be trying to define responders to cardiac resynchronization therapy?
Cleland JG; Tageldien A; Buga L; Wong K; Gorcsan J
JACC Cardiovasc Imaging; 2010 May; 3(5):541-9. PubMed ID: 20466352
[No Abstract] [Full Text] [Related]
47. Neuroimaging in rehabilitation: a resource for clinicians.
Shields RK
Phys Ther; 2007 Jun; 87(6):639-40. PubMed ID: 17504824
[No Abstract] [Full Text] [Related]
48. Molecular imaging I. Preface.
Semmler W; Schwaiger M
Handb Exp Pharmacol; 2008; (185 Pt 1):vii-ix. PubMed ID: 18763375
[No Abstract] [Full Text] [Related]
49. The role of cardiovascular magnetic resonance imaging in heart failure.
Karamitsos TD; Francis JM; Myerson S; Selvanayagam JB; Neubauer S
J Am Coll Cardiol; 2009 Oct; 54(15):1407-24. PubMed ID: 19796734
[TBL] [Abstract][Full Text] [Related]
50. Future of nuclear medicine: SPECT versus PET.
Gholamrezanejhad A; Mirpour S; Mariani G
J Nucl Med; 2009 Jul; 50(7):16N-18N. PubMed ID: 19652221
[No Abstract] [Full Text] [Related]
51. An advance in molecular imaging of dementias.
Albin RL
Lancet Neurol; 2007 Apr; 6(4):288-9. PubMed ID: 17362826
[No Abstract] [Full Text] [Related]
52. Arterial load reduction after cardiac resynchronization therapy: why does it change?
Zócalo Y; Bia D; Reyes-Caorsi W; González-Moreno J; Armentano RL
Eur J Echocardiogr; 2009 Jun; 10(4):461-2; author reply 462-3. PubMed ID: 19398475
[No Abstract] [Full Text] [Related]
53. Molecular-functional imaging of cancer: to image and imagine.
Glunde K; Pathak AP; Bhujwalla ZM
Trends Mol Med; 2007 Jul; 13(7):287-97. PubMed ID: 17544849
[TBL] [Abstract][Full Text] [Related]
54. Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period.
Harinstein ME; Flaherty JD; Fonarow GC; Mehra MR; Lang RM; Kim RJ; Cleland JG; Knight BP; Pang PS; Bonow RO; Gheorghiade M
Heart; 2011 Oct; 97(19):1607-18. PubMed ID: 21900586
[No Abstract] [Full Text] [Related]
55. Screening: the new frontier in heart failure management.
McGrady M; Krum H
Cardiovasc Ther; 2009; 27(1):1-3. PubMed ID: 19207473
[No Abstract] [Full Text] [Related]
56. Seeing is believing.
Meade T
Acad Radiol; 2001 Jan; 8(1):1-3. PubMed ID: 11201450
[No Abstract] [Full Text] [Related]
57. [Role of MRI in diagnosis of heart failure].
Garot J
Rev Prat; 2010 Sep; 60(7):930-2. PubMed ID: 21033487
[No Abstract] [Full Text] [Related]
58. Whole body imaging.
Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):381. PubMed ID: 19414232
[No Abstract] [Full Text] [Related]
59. Reporter chemistry universalises radiochemistry.
Kopka K
Nuklearmedizin; 2005; 44(6):225-7. PubMed ID: 16400381
[No Abstract] [Full Text] [Related]
60. Perspectives on PET/MR imaging: are we ready for clinical use?
Mansi L; Ciarmiello A
J Nucl Med; 2014 Apr; 55(4):529-30. PubMed ID: 24556592
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
